AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DEFERASIROX
83 registrations across 12 African markets— 60 active
Markets with DEFERASIROX
🇬🇭Ghana
15 registrations
10 active
🇿🇦South Africa
12 registrations
6 active
🇹🇳Tunisia
12 registrations
0 active
🇸🇳Senegal
9 registrations
9 active
🇲🇬Madagascar
6 registrations
6 active
🇲🇦Morocco
6 registrations
6 active
🇹🇿Tanzania
6 registrations
6 active
🇿🇼Zimbabwe
5 registrations
5 active
🇷🇼Rwanda
3 registrations
3 active
🇳🇬Nigeria
3 registrations
3 active
🇿🇲Zambia
3 registrations
3 active
🇨🇮Côte d'Ivoire
3 registrations
3 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FERASIRO 125 DT ORAL DESINTEGRATING TABLETS | 🇷🇼Rwanda | MSN Labs Private Limited | active | May 2031 |
| FERASIRO 500 DT ORAL DISINTEGRATING TABLETS | 🇷🇼Rwanda | MSN Labs Private Limited | active | May 2031 |
| FERASIRO 250 DT Film Coated Tablet | 🇷🇼Rwanda | MSN Labs Private Limited | active | May 2031 |
| JADAX 90 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| JADAX 360 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| JADAX 180 TABLET, COATED; ORAL | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Mar 2031 |
| JADAX 90 Film-coated Tablets | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Oct 2030 |
| JADAX 180mg Film-coated Tablets | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Oct 2030 |
| JADAX 360mg Film Coated Tablets | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Oct 2030 |
| SIROXTRIN 250 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Mar 2030 |
| SIROXTRIN 500 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Mar 2030 |
| SIROXTRIN 125 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Mar 2030 |
| SIROXTRIN 500 | 🇿🇦South Africa | Trinity Pharma (Pty) Ltd | active | Mar 2030 |
| DEFETOR-500 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Jun 2028 |
| DEFETOR 250 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Jun 2028 |
| Oleptiss 360 mg Film-coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2028 |
| Oleptiss 90 mg Film-coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2028 |
| Oleptiss 180 mg Film-coated Tablet** Tablet | 🇳🇬Nigeria | Novartis Nigeria Limited | active | May 2028 |
| OLEPTISS TABLETS (Each film coated tablet contains; Deferasirox 90mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| OLEPTISS 180mg TABLETS (Each film coated tablet contains; Deferasirox 180mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| OLEPTISS FILM COATED TABLETS (Each film-coated tablet contains Deferasirox 180mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film-coated tablet contains Deferasirox 360mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| OLEPTISS FILM COATED TABLETS (Each film-coated tablet contains Deferasirox 180mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS TABLETS (Each film coated tablet contains; Deferasirox 90mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS TABLETS (Each film coated tablet contains; Deferasirox 90mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film-coated tablet contains Deferasirox 360mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS FILM COATED TABLETS (Each film-coated tablet contains Deferasirox 180mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film-coated tablet contains Deferasirox 360mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film coated tablet contains; Deferasirox 360mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film coated tablet contains; Deferasirox 360mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS FILM-COATED TABLETS (Each film coated tablet contains; Deferasirox 360mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS 180mg TABLETS (Each film coated tablet contains; Deferasirox 180mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| OLEPTISS 180mg TABLETS (Each film coated tablet contains; Deferasirox 180mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| NUJADE 180 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| NUJADE 90 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| NUJADE 360 mg | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| DEFERASIROX 90 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| DEFERASIROX 180 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| DEFERASIROX 360 mg CIPLA | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | May 2026 |
| JADENU Comprimé pelliculé / 90MG | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Jun 2021 |
| JADENU Comprimé pelliculé / 360MG | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Jun 2021 |
| JADENU Comprimé pelliculé / 180MG | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Jun 2021 |
| DIFEXA Comprime dispersible / 500 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jan 2015 |
| DIFEXA Comprime dispersible / 250 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jan 2015 |
| DIFEXA Comprime dispersible / 125 mg | 🇹🇳Tunisia | TAHA PHARMA | expired | Jan 2015 |
| DEFEROX Comprime dispersible / 125 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2014 |
| DEFEROX Comprime dispersible / 250 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2014 |
| DEFEROX Comprime dispersible / 500 mg | 🇹🇳Tunisia | PHILADELPHIA PHARMA | expired | Nov 2014 |
| EXJADE Comprime dispersible / 250 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Jun 2009 |
| EXJADE Comprime dispersible / 500 MG | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Jun 2009 |
Showing 50 of 83 registrations. Sign up free to search and export all.
DEFERASIROX in Africa — Regulatory Overview
DEFERASIROX is registered across 12 African markets with 83 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Ghana, South Africa, Tunisia, Senegal and 8 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 83 registrations, 60 (72%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.